Exercise during chemo: a new weapon to preserve strength?
NCT ID NCT07764341
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether a supervised exercise program is practical and safe for women with early-stage breast cancer receiving chemotherapy before surgery. Participants either join a supervised aerobic and strength training program twice a week during chemo, or receive usual care. The study looks at whether women can stick with the program, if it's safe, and if it helps maintain muscle, strength, quality of life, and chemotherapy delivery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Supervised aerobic and resistance exercise
- What this could lead to
- If feasible, this could support a larger trial testing whether exercise during chemo helps women with breast cancer maintain muscle, strength, and quality of life.
- What could go wrong
- This is a small feasibility study, not a proof of effectiveness. Exercise may be hard to adhere to during chemo, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bahrain Oncology Center
Al Muharraq, Bahrain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new implant rebuild the breast right after lumpectomy?
- Could a smartphone program ease Chemo's emotional toll?
- Could fewer heart tests be safer for breast cancer patients?
- Personalizing chemo: enzyme test may guide capecitabine dosing
- New study aims to predict who will respond to breast cancer therapy
- Blood test could revolutionize breast cancer monitoring